Alicia Sable-Hunt
Overview
Explore the profile of Alicia Sable-Hunt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oxnard G, Chen R, Pharr J, Koeller D, Bertram A, Dahlberg S, et al.
J Clin Oncol
. 2023 Aug;
41(34):5274-5284.
PMID: 37579253
Purpose: The genomic underpinnings of inherited lung cancer risk are poorly understood. This prospective study characterized the clinical phenotype of patients and families with germline pathogenic variants (PVs). Methods: The...
2.
Gitlitz B, Novello S, Vavala T, Bittoni M, Sable-Hunt A, Pavlick D, et al.
JTO Clin Res Rep
. 2021 Sep;
2(7):100194.
PMID: 34590039
Introduction: Lung adenocarcinomas in young patients (<40 y) are more likely to harbor targetable genomic alterations. This study aimed to determine whether the prevalence of targetable alterations is greater in...
3.
SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA Genotyping
Lawrence M, Tamen R, Martinez P, Sable-Hunt A, Addario T, Barbour P, et al.
JTO Clin Res Rep
. 2021 Sep;
2(4):100151.
PMID: 34590008
Introduction: Remote consent and enrollment offer a unique opportunity to provide rare cancer populations with access to clinical research. The genomic analysis of plasma cell-free DNA (cfDNA) permits remote characterization...
4.
Ahmann G, Chng W, Henderson K, Price-Troska T, DeGoey R, Timm M, et al.
Cancer Epidemiol Biomarkers Prev
. 2008 Mar;
17(3):666-73.
PMID: 18349285
The Multiple Myeloma Research Consortium has established a tissue bank for the deposition of bone marrow samples from patients with multiple myeloma to be mailed and processed under good laboratory...